Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Alonso-Romero JL, Martinez-Garcia J, Carrillo-Vicente R, Aramburo AF, Diez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jimenez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreno PR. Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat. 2026 Jan 20;215(2):60. doi: 10.1007/s10549-026-07895-8. PubMed PMID: 41557021; PubMed Central PMCID: PMC12819485.
AÑO: 2026; IF: 3.0
41557021
Fernandez O, Molina A, Anido-Herranz U, Alvarez C, Girones R, Gajate P, Dominguez RG, Ros S, Puente J, Blasco S, Ore-Arce M, Martinez EN, Fernandez-Freire A, Del Pozo N, Cassinello J, Lazaro-Quintela M, Arranz F, Crespo G, Abad MT, Llorente M, Sanchez-Hernandez A, Juan MJ. Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study. Clin Transl Oncol. 2026 Jan;28(1):254-264. doi: 10.1007/s12094-025-03978-y. Epub 2025 Jul 9. PubMed PMID: 40629216; PubMed Central PMCID: PMC12790522.
AÑO: 2026; IF: 2.5
40629216
Ibanez N, Abrisqueta J, Encarnacion JA, Hernandez Q. Neoadjuvant therapy and the Watch and Wait strategy in rectal cancer diagnosed after sex reassignment surgery. Cir Esp (Engl Ed). 2026 Feb 5:800299. doi: 10.1016/j.cireng.2026.800299. Online ahead of print. No abstract available. PubMed PMID: 41654118.
AÑO: 2026; IF: 1.3
41654118
Lopez-Tarruella S, Guerrero-Zotano A, Antolin S, Cruz J, Martinez P, Rodriguez CA, Falo C, Rodriguez-Lescure A, Adrover E, Hernandez M, Andres R, Chacon JI, Alonso Romero JL, Miguel A, Gomez-Raposo C, Margeli M, Gonzalez I, Guerra JA, Anton A, Tibau A, Miralles JJ, Escudero MJ, Bezares S, Rojo F, Alvarez I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Ther Adv Med Oncol. 2026 Feb 20;18:17588359261421813. doi: 10.1177/17588359261421813. eCollection 2026. PubMed PMID: 41732657; PubMed Central PMCID: PMC12924966.
AÑO: 2026; IF: 4.2
41732657
Rosado-Jiménez L., Mestre-Terkemani Y., García-Aliaga Á., Sarabia-Meseguer M.D., Marín-Vera M., Macías-Cerrolaza J.A., Sánchez-Henarejos P., García-Hernández M.R., Zafra-Poves M., Álvarez-Abril B.C., López-Sánchez C.B., Moya-Martínez M.P., Pascual-Gilabert P., Cerón-Moreno A.M., Castillo-Guardiola V., Antón-Martínez D., Ayala-de la Peña F., Alonso-Romero J.L., Noguera-Velasco J.A., Ruiz-Espejo F. Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes. Familial Cancer. March 2026. 25. 10.1007/s10689-025-00521-4
AÑO: 2026; IF: 2.0
41410715
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL